Learning in Recovery from Disruption: Empirical Evidence from the U.S. Drug Shortages

Published Online:https://doi.org/10.1287/mnsc.2024.08337

References

  • Adler PS (1990) Shared learning. Management Sci. 36(8):938–957.LinkGoogle Scholar
  • Angelis A, Polyakov R, Wouters OJ, Torreele E, McKee M (2023) High drug prices are not justified by industry’s spending on research and development. The BMJ 380.CrossrefGoogle Scholar
  • Angrist JD, Pischke JS (2009) Mostly Harmless Econometrics: An Empiricist’s Companion (Princeton University Press, Princeton, NJ).CrossrefGoogle Scholar
  • Argote L, Epple D (1990) Learning curves in manufacturing. Science 247(4945):920–924.CrossrefGoogle Scholar
  • Argote L, Miron-Spektor E (2011) Organizational learning: From experience to knowledge. Organ. Sci. 22(5):1123–1137.LinkGoogle Scholar
  • Bavafa H, Jonasson JO (2021) The variance learning curve. Management Sci. 67(5):3104–3116.LinkGoogle Scholar
  • Benkard CL (2000) Learning and forgetting: The dynamics of aircraft production. Amer. Econom. Rev. 90(4):1034–1054.CrossrefGoogle Scholar
  • Berndt ER, Mortimer R, Bhattacharjya A, Parece A, Tuttle E (2007) Authorized generic drugs, price competition, and consumers’ welfare. Health Affairs 26(3):790–799.CrossrefGoogle Scholar
  • Bohn RE (1995) Noise and learning in semiconductor manufacturing. Management Sci. 41(1):31–42.LinkGoogle Scholar
  • Burton TM (2019) FDA recommends measures to curb drug shortages. Wall Street Journal (October 29), https://www.wsj.com/articles/fda-recommends-measures-to-curb-drug-shortages-11572379999.Google Scholar
  • Cantillon P, Macdermott M (2008) Does responsibility drive learning? Lessons from intern rotations in general practice. Medical Teacher 30(3):254–259.CrossrefGoogle Scholar
  • Clark JR, Huckman RS, Staats BR (2013) Learning from customers: Individual and organizational effects in outsourced radiological services. Organ. Sci. 24(5):1539–1557.LinkGoogle Scholar
  • Cornelius PB, Gokpinar B, Sting FJ (2021) Sparking manufacturing innovation: How temporary interplant assignments increase employee idea values. Management Sci. 67(4):2231–2250.LinkGoogle Scholar
  • Darr ED, Argote L, Epple D (1995) The acquisition, transfer, and depreciation of knowledge in service organizations: Productivity in franchises. Management Sci. 41(11):1750–1762.LinkGoogle Scholar
  • Edwards E (2021) The U.S. needs to reimagine its pharma supply chain. Harvard Bus. Rev. (August 12), https://hbr.org/2021/08/the-u-s-needs-to-reimagine-its-pharma-supply-chain.Google Scholar
  • Epple D, Argote L, Devadas R (1991) Organizational learning curves: A method for investigating intra-plant transfer of knowledge acquired through learning by doing. Organ. Sci. 2(1):58–70.LinkGoogle Scholar
  • FDA (2015) Production and process controls: Overview of CGMP regulations and regulatory expectations. U.S. Food and Drug Administration.Google Scholar
  • FDA (2017) Introduction to complex products and FDA considerations. U.S. Food and Drug Administration.Google Scholar
  • FDA (2019) Drug shortages: Root causes and potential solutions. U.S. Food and Drug Administration.Google Scholar
  • FDA (2022) Frequently asked questions about drug shortages. U.S. Food and Drug Administration.Google Scholar
  • FDA (2024) Reporting Amount of Listed Drugs and Biological Products under Section 510(j)(3) of the Federal Food, Drug, and Cosmetic Act. U.S. Food and Drug Administration, Docket No. FDA-2021-D-1031, Guidance for Industry.Google Scholar
  • Fink S (2016) Drug shortages forcing hard decisions on rationing treatments. New York Times (January 29), https://www.nytimes.com/2016/01/29/us/drug-shortages-forcing-hard-decisions-on-rationing-treatments.html.Google Scholar
  • Fox ER, Tyler LS (2003) Managing drug shortages: Seven years’ experience at one health system. Amer. J. Health-System Pharmacy 60(3):245–253.CrossrefGoogle Scholar
  • Fox ER, Sweet BV, Jensen V (2014) Drug shortages: A complex health care crisis. Mayo Clin. Proc. 89(3):361–373.CrossrefGoogle Scholar
  • Fox ER, Birt A, James K, Kokko H, Salverson S, Soflin D (2009) ASHP guidelines on managing drug product shortages in hospitals and health systems. Amer. J. Health-System Pharmacy 66(15):1399–1406.Google Scholar
  • Fry E (2018) Critical condition: Inside Pfizer’s drug supply problem. Fortune (May 22), https://fortune.com/longform/pfizer-drug-problem-fortune-500/.Google Scholar
  • GAO (2014) Drug shortages: Public health threat continues, despite efforts to help ensure product availability. U.S. Government Accountability Office GAO-14-194.Google Scholar
  • Gatesman ML, Smith TJ (2011) The shortage of essential chemotherapy drugs in the United States. New England J. Medicine 365(18):1653–1655.CrossrefGoogle Scholar
  • Gray JV, Siemsen E, Vasudeva G (2015) Colocation still matters: Conformance quality and the interdependence of R&D and manufacturing in the pharmaceutical industry. Management Sci. 61(11):2760–2781.LinkGoogle Scholar
  • Guajardo J, Cohen M, Kim S, Netessine S (2012) Impact of performance-based contracting on product reliability: An empirical analysis. Management Sci. 58(5):961–979.LinkGoogle Scholar
  • Haunschild PR, Rhee M (2004) The role of volition in organizational learning: The case of automotive product recalls. Management Sci. 50(11):1545–1560.LinkGoogle Scholar
  • Haunschild PR, Sullivan BN (2002) Learning from complexity: Effects of prior accidents and incidents on airlines’ learning. Admin. Sci. Quart. 47(4):609–643.CrossrefGoogle Scholar
  • Hu X, Gurnani H, Wang L (2013) Managing risk of supply disruptions: Incentives for capacity restoration. Production Oper. Management 22(1):137–150.CrossrefGoogle Scholar
  • Huckman RS, Pisano GP (2006) The firm specificity of individual performance: Evidence from cardiac surgery. Management Sci. 52(4):473–488.LinkGoogle Scholar
  • Ivanov D, Dolgui A, Sokolov B, Ivanova M (2017) Literature review on disruption recovery in the supply chain. Internat. J. Production Res. 55(20):6158–6174.CrossrefGoogle Scholar
  • Iyer AV, Deshpande V, Wu Z (2005) Contingency management under asymmetric information. Oper. Res. Let. 33(6):572–580.CrossrefGoogle Scholar
  • Jacob EC (2020) Factors involved in US generic drug shortages. US Pharm. 45(6):19–24.Google Scholar
  • Jensen V, Rappaport BA (2010) The reality of drug shortages-the case of the injectable agent propofol. New England J. Medicine 363(9):806–807.CrossrefGoogle Scholar
  • Jia J, Zhao H (2017) Mitigating the US drug shortages through pareto-improving contracts. Production Oper. Management 26(8):1463–1480.CrossrefGoogle Scholar
  • Kaiser J (2011) Shortages of cancer drugs put patients, trials at risk. Science (1979) 332(6029):523–523.Google Scholar
  • Kane AA, Argote L, Levine JM (2005) Knowledge transfer between groups via personnel rotation: Effects of social identity and knowledge quality. Organ. Behav. Human Decision Processes 96(1):56–71.CrossrefGoogle Scholar
  • Kc DS, Staats BR, Gino F (2013) Learning from my success and from others’ failure: Evidence from minimally invasive cardiac surgery. Management Sci. 59(11):2435–2449.LinkGoogle Scholar
  • Kesavan S, Staats BR, Gilland W (2014) Volume flexibility in services: The costs and benefits of flexible labor resources. Management Sci. 60(8):1884–1906.LinkGoogle Scholar
  • Kim SH, Kim BC (2014) Differential effects of prior experience on the malware resolution process. MIS Quart. 38(3):655–678.CrossrefGoogle Scholar
  • Kim JY, Miner AS (2007) Vicarious learning from the failures and near-failures of others: Evidence from the U.S. commercial banking industry. Acad. Management J. 50(3):687–714.CrossrefGoogle Scholar
  • Kim SH, Scott Morton F (2015) A model of generic drug shortages: Supply disruptions, demand substitution, and price control. Working paper, Yale School of Management, Yale University, New Haven, CT.Google Scholar
  • Kim SH, Tomlin B (2013) Guilt by association: Strategic failure prevention and recovery capacity investments. Management Sci. 59(7):1631–1649.LinkGoogle Scholar
  • Lapré MA, Cravey C (2022) When success is rare and competitive: Learning from others’ success and my failure at the speed of formula one. Management Sci. 68(12):8741–8756.LinkGoogle Scholar
  • Lapré MA, Tsikriktsis N (2006) Organizational learning curves for customer dissatisfaction: Heterogeneity across airlines. Management Sci. 52(5):352–366.LinkGoogle Scholar
  • Lee J (2018) Higher prices could cure some drug shortages, FDA chief says. Bloomberg Law. (November 16), https://news.bloomberglaw.com/pharma-and-life-sciences/higher-prices-could-cure-some-drug-shortages-fda-chief-says.Google Scholar
  • Lee HS, Kesavan S, Deshpande V (2021a) Managing the impact of fitting-room traffic on retail sales: Using labor to reduce phantom stockouts. Manufacturing Service Oper. Management 23(6):1580–1596.LinkGoogle Scholar
  • Lee J, Lee HS, Shin H, Vish K (2021b) Alleviating drug shortages: The role of mandated reporting induced operational transparency. Management Sci. 67(4):2326–2339.LinkGoogle Scholar
  • Lu G, Lee HS, Son J (2022) Product variety in grocery stores: Its differential effects on stock-keeping unit level sales. J. Oper. Management 68(1):33–54.CrossrefGoogle Scholar
  • Madsen PM, Desai V (2010) Failing to learn? The effects of failure and success on organizational learning in the global orbital launch vehicle industry. Acad. Management J. 53(3):451–476.CrossrefGoogle Scholar
  • Myers CG, Staats BR, Gino F (2014) “My Bad!”: How Internal Attribution and Ambiguity of Responsibility Affect Learning from Failure (Harvard Business School, Boston).Google Scholar
  • Narayanan S, Balasubramanian S, Swaminathan JM (2009) A matter of balance: Specialization, task variety, and individual learning in a software maintenance environment. Management Sci. 55(11):1861–1876.LinkGoogle Scholar
  • National Academies of Sciences, Engineering, and Medicine (2022) Building Resilience into the Nation’s Medical Product Supply Chains (The National Academies Press, Washington, DC).Google Scholar
  • Naumov S, Noh IJ, Zhao H (2025) Evaluating quality reward and other interventions to mitigate US drug shortages. J. Oper. Management 71(3):335–372.CrossrefGoogle Scholar
  • Nevo A, Wolfram C (2002) Why do manufacturers issue coupons? An empirical analysis of breakfast cereals. RAND. J. Econom. 33(2):319–339.CrossrefGoogle Scholar
  • Noh IJ, Gray J, Ball G, Wright Z, Park H (2025) Are all generic drugs created equal? An empirical analysis of generic drug manufacturing location and serious drug adverse events. Production Oper. Management 34(9):2601–2617.CrossrefGoogle Scholar
  • Palepu K (1985) Diversification strategy, profit performance and the entropy measure. Strategic Management J. 6(3):239–255.CrossrefGoogle Scholar
  • Park M, Carson AL, Fox ER, Conti RM (2024) Stockpiling at the onset of the COVID-19 pandemic: An empirical analysis of national prescription drug sales and prices. Management Sci. 70(10):6483–6501.LinkGoogle Scholar
  • Parker-Lue S, Lieberman M (2020) The impact of diversification on task performance: Evidence from kidney transplant centers. Strategic Management J. 41(7):1169–1190.CrossrefGoogle Scholar
  • Phillips R, Şimşek A, Van Ryzin G (2015) The effectiveness of field price discretion: Empirical evidence from auto lending. Management Sci. 61(8):1741–1759.LinkGoogle Scholar
  • Reiffen D, Ward MR (2005) Generic drug industry dynamics. Rev. Econom. Statist. 87(1):37–49.CrossrefGoogle Scholar
  • Schilling MA, Vidal P, Ployhart RE, Marangoni A (2003) Learning by doing something else: Variation, relatedness, and the learning curve. Management Sci. 49(1):39–56.LinkGoogle Scholar
  • Shah R, Ball GP, Netessine S (2017) Plant operations and product recalls in the automotive industry: An empirical investigation. Management Sci. 63(8):2439–2459.LinkGoogle Scholar
  • Soltani M, Batt RJ, Bavafa H, Patterson BW (2022) Does what happens in the ED stay in the ED? The effects of emergency department physician workload on post-ED care use. Manufacturing Service Oper. Management 24(6):3079–3098.LinkGoogle Scholar
  • Staats BR, Gino F (2012) Specialization and variety in repetitive tasks: Evidence from a Japanese bank. Management Sci. 58(6):1141–1159.LinkGoogle Scholar
  • Staiger D, Stock J (1997) Instrumental variables regression with weak instruments. Econometrica 65(3):557–586.CrossrefGoogle Scholar
  • Tomlin B (2006) On the value of mitigation and contingency strategies for managing supply chain disruption risks. Management Sci. 52(5):639–657.LinkGoogle Scholar
  • Ton Z, Huckman RS (2008) Managing the impact of employee turnover on performance: The role of process conformance. Organ. Sci. 19(1):56–68.LinkGoogle Scholar
  • Tucker EL, Cao Y, Fox ER, Sweet BV (2020) The drug shortage era: A scoping review of the literature 2001–2019. Clin. Pharmacology Therapeutics 108(6):1150–1155.CrossrefGoogle Scholar
  • Wiersma E (2007) Conditions that shape the learning curve: Factors that increase the ability and opportunity to learn. Management Sci. 53(12):1903–1915.LinkGoogle Scholar
  • Woodcock J, Wosinska M (2013) Economic and technological drivers of generic sterile injectable drug shortages. Clinical Pharmacology Therapeutics 93(2):170–176.Google Scholar
  • Wooldridge J (2015) Control function methods in applied econometrics. J. Human Resources 50(2):420–445.CrossrefGoogle Scholar
  • Yang Z, Aydın G, Babich V, Beil DR (2012) Using a dual-sourcing option in the presence of asymmetric information about supplier reliability: Competition vs. diversification. Manufacturing Service Oper. Management 14(2):202–217.LinkGoogle Scholar
  • Yelle LE (1979) The learning curve: Historical review and comprehensive survey. Decision Sci. 10(2):302–328.CrossrefGoogle Scholar
  • Yurukoglu A, Liebman E, Ridley DB (2017) The role of government reimbursement in drug shortages. Amer. Econom. J. Policy 9(2):348–382.CrossrefGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.